Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001382963-15-000070)

Filing Details

Accession Number:: 0001382963-15-000070
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-06-25 21:03:22
Reporting Period:: 2015-06-24

Filing Date:: 2015-06-25
Accepted Time:: 2015-06-25 21:03:22
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1460702	Ritter Pharmaceuticals Inc	RTTR	Pharmaceutical Preparations (2834)	263474527

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1631673	Noah Doyle	Ritter Pharmaceuticals, Inc. 1801 Century Park East, #1820 Los Angeles, CA 90067		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2015-06-24	800,000	$5.00	800,000	No	4	P	Indirect	by Javelin Venture Partners, L.P.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	by Javelin Venture Partners, L.P.

Footnotes

As the managing director of Javelin Venture Partners, L.P. the reporting person may be deemed the beneficial owner of these shares. The reporting person expressly disclaims beneficial ownership over these shares except to the extent of his pecuniary interest therein.